Pictured: Diversity Programs
On Our Website
By Memorial Sloan Kettering  |  Monday, December 31, 2012

Our Office of Diversity Programs offers information and resources about clinical care, research, and training focused on reducing cancer health disparities in medically underserved populations.

Pictured: Marcel R. M. van den Brink
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Friday, December 21, 2012

Memorial Sloan Kettering researchers have shown for the first time that administering a growth factor called interleukin-7 can help patients regenerate T cells more quickly after stem cell transplantation.

Pictured: X-ray Image
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Wednesday, December 19, 2012

Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.

Pictured: Michel Sadelain
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, December 18, 2012

Memorial Sloan Kettering researchers have reported a new method that could allow the development of more-specific, cell-based therapies for cancer.

Pictured: Ming Li
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, December 14, 2012

Recent findings by Memorial Sloan Kettering immunologists might one day pave the way for new strategies to control a range of diseases, including autoimmune disorders and cancer.

Pictured: Michel Sadelain & Jedd Wolchok
Announcement
By Media Staff  |  Wednesday, December 12, 2012

Physician-scientists Michel Sadelain and Jedd Wolchok have been appointed to a new research team dedicated to investigating ways to harness the immune system to fight cancer.

Pictured: Lorenz Studer
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, December 11, 2012

Methods to generate stem cells have given scientists new ways to study some diseases and identify potential drugs, and could one day be used to rebuild diseased or damaged tissues in patients.

Pictured: Charles Sawyers
Announcement
By Media Staff  |  Saturday, December 8, 2012

Charles Sawyers, Chair of Memorial Sloan Kettering’s Human Oncology and Pathogenesis Program, is widely recognized as someone who is revolutionizing the molecular treatment of cancer.

Research
Pictured: Paul Chapman
Finding
By Memorial Sloan Kettering  |  Friday, December 7, 2012

Memorial Sloan Kettering experts add to their knowledge of vemurafenib, a drug recently approved by the FDA to treat some patients with metastatic melanoma.

Pictured: 2012 Rock Stars of Science
Announcement
By Allyson Collins, MS, Science Writer/Editor  |  Thursday, December 6, 2012

The initiative, focused on investigators from Memorial Sloan Kettering’s Geoffrey Beene Cancer Research Center, highlights the critical need for funding scientific research.

Pictured: Michael Zelefsky
In the Clinic
By Andrea Peirce, BA and Media Staff
Friday, November 30, 2012

Study signals hope for maintaining sexual function in men undergoing radiation treatment for prostate cancer.

Pictured: Michael Berger & David Solit
Feature
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, November 26, 2012

At Memorial Sloan Kettering, new technologies to study gene changes in cancer cells are accelerating the development and implementation of more-effective treatments.

Pictured: Scott Lowe
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, November 19, 2012

In the lab of cancer biologist Scott Lowe, researchers are investigating the processes that naturally inhibit cancer development.

Pictured: PET Scan
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, November 15, 2012

Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.

Pictured: Marc Ladanyi & Snjezana Dogan
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Friday, November 9, 2012

A genetic analysis of tumors suggests women are more susceptible than men to the most common form of lung cancer.

Center News

Stay Informed

Get the latest information about cancer care and research every month.